,925,174
Long-term loans and payables -
current portion 431,041 331,693
Accounts payable - related party 880,167 880,026
Accounts payable - third parties 4,033,650 344,774
Income tax payable 4,901,251 4,082,424
Advance from customers 31,311 29,157
Accrued expenses 894,985 479,609
Due to a related party 785,765 1,663,191
Other payables 411,182 553,286
Derivative liabilities - fair value
of warrants 1,367,671 1,380,205
Total Current Liabilities 13,737,023 12,669,539
Long-term loans and payables 769,737 545,327
Total Liabilities 14,506,760 13,214,866
Equity
Yongye International, Inc.
shareholders' equity:
Common stock: par value $.001;
75,000,000 shares authorized;
44,532,241 shares issued and
outstanding at March 31, 2010 and
December 31, 2009 44,532 44,532
Additional paid-in capital 118,583,308 118,583,308
Subscription receivable -- (8,550,000)
Retained earnings 19,877,738 15,506,445
Accumulated other comprehensive
income 349,491 329,139
Total Yongye International, Inc.
shareholders' equity 138,855,069 125,913,424
Noncontrolling interest 6,935,918 6,677,398
Total Equity 145,790,987 132,590,822
Total Liabilities and Equity $160,297,747 $145,805,688
'/>"/>SOURCE Yongye International, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related biology technology :1.
Yongye International Announces Conference Call to Discuss First Quarter Fiscal Year 2010 Results2.
Yongye International to Present at Upcoming Investor Conferences3.
Yongye International, Inc. Begins Construction of New Production Facility4.
Yongye International Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Results5.
Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results6.
Yongye International Announces 2010-2012 Strategic Plan7.
Yongye International Announces Expansion of Research and Development Center8.
Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores9.
Yongye Biotechnology International Receives License to Manufacture Products10.
Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance11.
Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day